Pharmaceutical grade lactose market key companies profile, overview and research insights and trends
Pharmaceutical Grade Lactose Market Key Companies Profile, Overview
and Research Insights and Trends
This Report Provides In-Depth Qualitative and Overall Analysis of the”
Pharmaceutical Grade Lactose Market” on a Regional Level from 2018 to 2023. The
Study also Provides a Comprehensive Review of Restraints, Market Dynamics,
Drivers and Opportunities Along with their Impact on the Overall Market. The report
Segments the Industry and Key Developments and Strategies for Key Players.
The pharmaceutical grade lactose market is segmented on the basis of type, and
application. On the basis of type, the market is segmented into crystalline monohydrate
lactose, inhalation lactose, granulated lactose, spray dried lactose, and others.
Crystalline monohydrate lactose is further segmented into α-Lactose monohydrate, and β-
Lactose (anhydrous lactose). Sub-segmentation of α-Lactose monohydrate includes milled
and sieved. Inhalation lactose is further segmented into sieved and milled.
Request Free Sample Copy at:
On the basis of application, the market is classified into tablets manufacturing, capsule
manufacturing, and others. Tablets manufacturing is further classified into direct
compression, wet granulation, and dry granulation. Capsule manufacturing is further
classified into capsules, sachets, and others.
Pharmaceutical Grade Lactose Market – Key Players
BASF SE, Merck KGaA, Kerry Inc. DFE Pharma, Meggle, Armor Pharma, ALPAVIT, and others
are some of the prominent players at the forefront of competition in the pharmaceutical
grade lactose market and are profiled in MRFR Analysis.
Pharmaceutical Grade Lactose Market – Overview
The pharmaceutical grade lactose market is growing mainly due to efficient compatibility
of lactose with active ingredients. According to a recent study report published by the
Market Research Future, the pharmaceutical grade lactose market is booming and expected
to gain prominence over the forecast period.
The market is forecast to demonstrate a spectacular growth by 2023, surpassing its
previous growth records in terms of value with a striking CAGR during the anticipated
period (2017 – 2023). Pharmaceutical grade lactose is a specialized grade of lactose that
meets the rigid pharmaceutical expectations. It is produced by concentrating whey or
permeate to over-saturate the lactose, which is then further refined, dried, and milled
Pharmaceutical grade lactose is manufactured in different specialty and customized range
to use in various oral solid dosage forms (OSDFs) such as tablets, capsules, sachets, dry
powder inhalers and others. Rising approval from government bodies to use
pharmaceutical grade lactose as an excipient is the primary driver for pharmaceutical
grade lactose market.
Due to broad availability and cost effectiveness, lactose is getting great acceptance across
the world. According 2017 updated inactive ingredient database by FDA, lactose is
approved to use as an excipient for different dosage forms. Other push factors such as,
compatibility with active ingredients and other excipients, and increasing demand for dry
powder inhalers (DPI) products are also fuelling the growth of the market. With the
increasing advancement, the usage of dry powder inhalers is also expanding for the
delivery of different drugs.
Using DPI technique an effective plasma concentration of levonorgestrel drug can be
exceeded over a period of 16-60 hours in comparison to the oral delivery. According to
FDA, lactose along with glucose and mannitol can be used as carriers in DPIs.
Despite these drivers, lactose-induced problems, stringent government regulations, and
lack of compatibility with amine-based drugs are expected to hinder the growth of the
market. Although lactose has been widely accepted for inhalation products, but it is not
compatible with proteins. According to a study published in the Revista Mexicana de
Ciencias (Mexican Journal of Sciences) in 2015, lactose has propensity to react with
primary and secondary amine drugs through Maillard reaction to produce colored
Pharmaceutical Grade Lactose Market – Competitive Analysis
Due to rising research and development expenditure various existing and new marketers
are continuously coming up with more advanced products. The global pharmaceutical
grade lactose market is currently dominated by very few players.
Kerry Inc. is one among them, by holding a strong position globally. It has a global
presence, however more than 60% of its share come from European region. This shows
strong grip on the European market, however, only 40% of the share comes from the rest
of the world, which includes countries like India, China, etc. The strategic alliance of
Foremost Farms, Sheffield Bio-Science, and Kerry Group is expected to promote the
pharmaceutical grade lactose products. The lactose is sold internationally under the Fast
Flo trademarks and foremost trademarks. Acquiring Lactose (India) Limited, was also a
part of strategy.
BASF SE is another renowned player in the pharmaceutical grade lactose market. The
company’s stronghold is largely attributed to its innovative and sustainable products. The
company provides customized products to make drug formation processes more efficient.
Pharmaceutical grade lactose products are covered under “Nutrition & Health” segment of
the company. In 2016, the “Nutrition & Health” was having revenue of USD 2251.39 million.
DFE Pharma is well-known for its broad range of lactose offerings in the pharmaceutical
industry. Its position among the key pharmaceutical grade lactose manufacturers is due to
its global footprint through distributors and agents. In October 2014, the company opened
a new sales office in Shanghai, China to effectively meet the escalating demand for
excipients products in China. In April 2014, the company has also opened a new sales office
in São Paulo, Brazil to strengthen its position in South and Central American countries.
Browse Detailed TOC with COVID-19 Impact Analysis at:
Over the past years, Merck KGaA has also transformed from a supplier of pharmaceutical
and chemicals into a global science & technology company with the acquisition of various
companies such as Sigma Aldrich in the year 2015. The company has portfolio in three
business sectors, Life Science, Healthcare, and Performance materials.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312